Ireland
--:--IST
Recruiting Not applicable

Potential of Virtual Reality in Primary Chronic Low Back Pain

NCT07742111 · tracked via the Priya Life Science Portugal tracker
Phase
Not applicable
Started
2026-05-01
Last updated
2026-08-03

Condition(s) studied

Low Back Pain

Investigational drug(s) / intervention(s)

Pain science education and virtual reality

Pain science education and virtual reality: The intervention period will take place between the 5th and the 29th day of the study (i.e., 3 weeks), noting that each participant will have a specific day to start the intervention. Three sessions will be conducted per week, with a total of 6 to 10 sessions per participant. The first 6 sessions will last 45 minutes, and the remaining 4 sessions will last 30 minutes. The sessions will combine Pain Neuroscience Education (PNE) and Virtual Reality (VR) using the Meta Quest 3S.

Study summary

This is a single-case experimental design study enrolling individuals with chronic low back pain who will be receiving pain science education and virtual reality over 3 weeks.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals with primary chronic low back pain aged ≥18 years, who present a moderate pain intensity (≥4 on the Numeric Pain Rating Scale) and a mild level of fear of movement. Exclusion Criteria: * have a diagnosis of spondylolisthesis or lumbar spinal stenosis; * are experiencing an exacerbation of low back pain symptoms at the time of screening; * present with constant and widespread nonspecific pain; * are in an active phase of rheumatoid arthritis; * have a progressive neurological disease; * are currently pregnant or within 6 months postpartum; * have a diagnosed psychiatric disorder; * have a malignant disease; * have serious cardiac conditions; * have contraindications to physical exercise in general;

Primary outcome measure(s)

  • Pain intensity — Baseline (Day 1)
    Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
  • Pain intensity — Daily (from day 1 to day 35)
    Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
  • Pain intensity — End of the intervention (day 35)
    Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.

Trial sites (1)

FacilityCityRegionStatus
General Community Amarante Portugal Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07742111 on ClinicalTrials.gov ↗ ← All trials in Portugal